Glycolysis and the Pentose Phosphate Pathway Promote LPS-Induced NOX2 Oxidase- and IFN-β-Dependent Inflammation in Macrophages.
LPS
NADPH oxidase
NOX2
glycolysis
inflammation
macrophages
pentose phosphate pathway
reactive oxygen species
Journal
Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981
Informations de publication
Date de publication:
29 Jul 2022
29 Jul 2022
Historique:
received:
17
06
2022
revised:
26
07
2022
accepted:
26
07
2022
entrez:
26
8
2022
pubmed:
27
8
2022
medline:
27
8
2022
Statut:
epublish
Résumé
Macrophages undergo a metabolic switch from oxidative phosphorylation to glycolysis when exposed to gram-negative bacterial lipopolysaccharide (LPS), which modulates antibacterial host defence mechanisms. Here, we show that LPS treatment of macrophages increased the classical oxidative burst response via the NADPH oxidase (NOX) 2 enzyme, which was blocked by 2-deoxyglucose (2-DG) inhibition of glycolysis. The inhibition of the pentose phosphate pathway with 6-aminonicotinamide (6-AN) also suppressed the LPS-induced increase in NOX2 activity and was associated with a significant reduction in the mRNA expression of NOX2 and its organizer protein p47phox. Notably, the LPS-dependent enhancement in NOX2 oxidase activity was independent of both succinate and mitochondrial reactive oxygen species (ROS) production. LPS also increased type I IFN-β expression, which was suppressed by 2-DG and 6-AN and, therefore, is dependent on glycolysis and the pentose phosphate pathway. The type I IFN-β response to LPS was also inhibited by apocynin pre-treatment, suggesting that NOX2-derived ROS promotes the TLR4-induced response to LPS. Moreover, recombinant IFN-β increased NOX2 oxidase-dependent ROS production, as well as NOX2 and p47phox expression. Our findings identify a previously undescribed molecular mechanism where both glycolysis and the pentose phosphate pathway are required to promote LPS-induced inflammation in macrophages.
Identifiants
pubmed: 36009206
pii: antiox11081488
doi: 10.3390/antiox11081488
pmc: PMC9405479
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : National Health and Medical Research Council
ID : 1122506
Organisme : National Health and Medical Research Council
ID : 1128276
Références
Biomark Insights. 2018 Feb 06;13:1177271918755391
pubmed: 29449774
Mini Rev Med Chem. 2009 Aug;9(9):1084-101
pubmed: 19689405
J Virol. 2014 Mar;88(6):3485-95
pubmed: 24403577
Clin Microbiol Rev. 2001 Oct;14(4):778-809, table of contents
pubmed: 11585785
Nature. 2013 Apr 11;496(7444):238-42
pubmed: 23535595
J Biol Chem. 2004 Mar 5;279(10):9424-31
pubmed: 14672929
Nucleic Acids Res. 2013 Jan;41(Database issue):D1040-6
pubmed: 23203888
Cell Rep. 2015 Jul 7;12(1):102-115
pubmed: 26119735
J Pediatr. 1989 Apr;114(4 Pt 1):555-60
pubmed: 2784499
Immunol Lett. 2017 Mar;183:17-23
pubmed: 28130076
Int J Mol Sci. 2012;13(9):10697-721
pubmed: 23109817
Free Radic Res. 2010 May;44(5):479-96
pubmed: 20370557
J Biol Chem. 1961 May;236:1534-43
pubmed: 13692277
Nat Rev Immunol. 2014 Jan;14(1):36-49
pubmed: 24362405
Free Radic Res. 2014 Aug;48(8):940-7
pubmed: 24869957
Adv Med. 2016;2016:9152732
pubmed: 27774507
Arch Toxicol. 2015 Aug;89(8):1209-26
pubmed: 26047665
Cell. 2016 Oct 6;167(2):457-470.e13
pubmed: 27667687
Redox Biol. 2014 Jan 10;2:206-10
pubmed: 24494194
Clin Sci (Lond). 2016 Apr 1;130(7):479-90
pubmed: 26888560
Cancer Cell. 2005 Jan;7(1):77-85
pubmed: 15652751
Nat Rev Immunol. 2019 May;19(5):291-304
pubmed: 30679807
Front Cell Neurosci. 2017 Jan 10;10:301
pubmed: 28119569
Antioxid Redox Signal. 2014 Jan 10;20(2):281-94
pubmed: 24053613
Free Radic Biol Med. 2011 Sep 1;51(5):978-92
pubmed: 21627987
Nat Commun. 2017 Jul 12;8(1):69
pubmed: 28701733
Oxid Med Cell Longev. 2017;2017:3496043
pubmed: 28255425
Nat Rev Immunol. 2016 Sep;16(9):553-65
pubmed: 27396447